Established in 1993, Hexagon Nutrition Ltd. is a research-driven nutrition enterprise specializing in the development and manufacture of micronutrient premixes, therapeutic formulations, branded wellness, clinical nutrition, and ready-to-use foods. The company leverages a strong manufacturing footprint consisting of three Indian facilities located in Nasik, Chennai, and Thoothukudi, alongside an international facility in Tashkent, Uzbekistan. Notably, its Chennai and Thoothukudi plants operate within Special Economic Zones (SEZs), offering strategic port proximity and duty-free import advantages.

Hexagon Nutrition’s diversified product portfolio spans three core business segments: branded wellness and clinical nutrition (B2C), premix formulations (B2B2C), and Ready-to-Use Foods (RUFs) and Micronutrient Powders (MNPs) under ESG initiatives. Domestically, the company commands a PAN-India omnichannel network supported by over 358 distributors. Globally, it has established offices in South Africa, Uzbekistan, and Hong Kong, exporting to over 75 countries. Operations are underpinned by two dedicated in-house R&D facilities in Nasik and Chennai.

For the year/period ended (Rs. in Cr.)

For year/ period ended ( in Cr.)

*Market cap @upper band

• Over two decades of expertise in micronutrient formulation, driving an established presence with specialized wellness and clinical nutrition brands across more than 70 countries.
• Advanced research and innovation capabilities seamlessly integrated with extensive manufacturing facilities that adhere strictly to rigorous global quality and food safety procedures.
• A well-established pan-India omnichannel distribution network that secures long standing relationships with marquee clients, ensuring consistent repeat orders and recurring revenue.
• Entrepreneurial, professional promoters and an experienced management team backed by a reputed institutional investor, delivering a proven track record of financial growth.

The Company HEXAGON NUTRITION LIMITED IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

• Carry out the Offer for Sale
• Achieve the benefits of listing the equity shares on the Stock Exchanges

At the upper band of IPO Rs. 45, the stock is valued at 15.35 P/E multiple. Hence, well-informed investors subscribe for medium to long term perspective.